• loading
  • +44 (0)20 8762 8008
  • Change Language
    [Close]
      • Language English
      • Language Japanese
      LanguageEnglish
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • Overview
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs

Quick Links

  • Home
  • About Us
  • Careers
  • CSR
  • Foundation
International SOS Logo
View Map
  • +44 (0)20 8762 8008 Call for Assistance
    • Language English
    • Language Japanese
    LanguageEnglish
  • Search
  • loading
    Log In
  • Home
  • Overview
    • Pandemic
    • Bird Flu
  • Subscribers
    • References
    • Planning Tools
    • Travel Advice
    • Email Sign up
  • Locations
  • Newsroom
    • News
    • Editorials
    • FAQs
  • About Us
  • Careers
  • CSR
  • Foundation
  • Pandemic Preparedness
  • 2019-nCoV
Print

COVID-19

 


Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

 

 

 

Member Access

 

Travel Restrictions, Flight Operations and Screening

Digital Passports

COVID-19 Digital Passports


Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID19 Vaccine FAQs

COVID-19 Vaccine FAQs

Variant

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice


 

COVID-19 Disease and Prevention Article


Sign up for Emails and Alerts

 

Premium Services Member Access

 

 

 

COVID-19 Manager Advice


 

COVID-19 Case Definitions used by different authorities

Impact Tool

Pandemic Local Impact Tool

COVID-19 Communication Material


 

COVID modelling with R0 equations

COVID-19 Modelling

COVID-19 Useful Links


 

HOT TOPICS (PREMIUM ACCESS)

  1. …
  2. 66
  3. 67
  4. 68
  5. 69
  6. 70
  7. …
  • Infection with human rhinovirus blocks SARS-CoV-2 replication, study

    23 March, 2021

    "...likely to have a population-wide effect as an increasing prevalence of rhinovirus will reduce the number of new COVID-19 cases."

    COVID-19

  • Children produce different antibodies for SARS-CoV-2 compared with adults: studies

    23 March, 2021

    Study finds young kids have strongest immune response to COVID-19...

    COVID-19

  • Oral, nasal COVID-19 vaccine candidates

    India // 23 March, 2021

    Oral and nasal vaccine candidates in India to undergo clinical trials

    COVID-19

  • Covishield second dose at 4 - 8 weeks

    India // 23 March, 2021

    Interval between first and second doses of Covishield increased

    COVID-19

  • Detections of the P.1 variant strain outside Brazil

    Brazil // Chile // Colombia // Denmark // France // Germany // India // Italy // Japan // Netherlands // Peru // South Korea // Spain // Switzerland // United Arab Emirates // United Kingdom // United States // Uruguay // 23 March, 2021

    Several countries have now detected the P.1 variant strain, first detected in Brazil...

    COVID-19

  • COVID deaths worldwide up for the first time in six weeks

    23 March, 2021

    After six weeks of going down, the worldwide death toll from COVID ...

    COVID-19

  • Higher vitamin D levels seem among black people who did not get COVID

    22 March, 2021

    A study showed that higher blood levels of vitamin D may have....

  • Past non-COVID vaccinations associated with decreased rates of SARS-CoV-2 infections, study

    22 March, 2021

    Vaccines that were given in the past one, two and five years...

    COVID-19

  • Phase 3 trial of AstraZeneca vaccine shows 79% efficacy

    United States // 22 March, 2021

    The independent data safety monitoring board found no increased risk of thrombosis...

    COVID-19

  • COVID-19 vaccines delivered – Eastern Mediterranean

    Afghanistan // Djibouti // Jordan // Palestinian Territory // Tunisia // Somalia // Sudan // 22 March, 2021

    The COVAX Facility have delivered more than 1.9 million doses to Afghanistan, Djibouti, Jordan, the occupied Palestinian territory, Tunisia, Somalia, and Sudan.

    COVID-19

  • Blood clots after AstraZeneca vaccination rare but might be linked to antibodies that develop against platelets

    21 March, 2021

    Researchers in Norway and Germany reach similar conclusions which are not yet verified...

    COVID-19

  • Developing skin tests for COVID

    20 March, 2021

    Skin swabs may eventually be used to detect...

    COVID-19

  • First local case in a month was vaccinated against COVID-19

    China // 20 March, 2021

    An infected person working in a hospital....

    COVID-19

  • Vaccine Update: Entire Adult Population Vaccinated

    Gibraltar // 19 March, 2021

    First in the world…

    COVID-19

  • CDC Updates Guidance for Schools

    United States // 19 March, 2021

    Social distancing differs by age group…

    COVID-19

  • Statement by WHO GACVS on saftety of Oxford/AstraZeneca vaccine

    19 March, 2021

    The subcommittee will continue to review the safety data from all COVID-19 vaccines...

    COVID-19

  • Hamburg Increases Restrictions

    Germany // 19 March, 2021

    New restrictions from 20-28 March…

    COVID-19

  • Vaccine update - vaccination groups expanded, companies must test employees for COVID-19 every week

    Czech Republic // 19 March, 2021

    People with chronic illnesses at high risk of severe disease will be eligible for vaccination from 24 March. Businesses with 10 or more employees must test....

    COVID-19

  • COVID-19 vaccine updates - vaccination rates improve, more vaccine centres open

    Kuwait // 19 March, 2021

    COVID-19 vaccine updates from Kuwait...

    COVID-19

  • Vaccine update - Suspension on AstraZeneca to be lifted

    Portugal // 19 March, 2021

    Portugal to resume AstraZeneca's vaccine

    COVID-19

  1. …
  2. 66
  3. 67
  4. 68
  5. 69
  6. 70
  7. …
  • Pandemic Home
  • Privacy
  • Contact Us
  • Feedback
  • Terms and Conditions
Footer Image


GeoNames logo

Additional data provided by

© 2024 International SOS